In the news

Most Read

  • Telkom CEO Sipho Maseko to step down
    Telkom has announced that its CEO and executive director Sipho Maseko will step down on 30 June 2022. The telecoms company said the process to appoint a successor is well underway and a designated group CEO will be announced in the not too distant future.
  • How cooking oil brought a moment of joy during a dreadful week
    It is possible that cooking oil prevented more looting in South Africa in the last week than the president, the ANC, the intelligence community, the army and the police combined. This, without question, says something about the versatility of the product. It says even more about the state of the state. When you are shown up by canola, you might want to revisit your strategy. By Howard Feldman
  • Park Advertising launches digital performance unit, Lucid Media
    Performance Media across Search, Social and Programmatic platforms is the single fastest growing area of digital media in South Africa. Combine that with the detailed analysis of campaign management, tagging and ad operations, and it becomes apparent that these highly specialist functions require a highly specialised unit.
  • Transnet hit by cyberattack - Operations disrupted nationwide
    The Transnet Port Terminals website has been hacked, implying that all companies under Transnet have been affected. All Transnet websites were down at the time when reporting was done for this SA Trucker article. The publication cited sources who requested to remain anonymous because they are not allowed to speak to the media.
  • #BehindtheBrandManager: Meet Tamsin Darroch of Kellogg's South Africa
    Few food brands have the historical connection with consumers around the world as Kellogg's does, having held meaning at the breakfast table for over a century. By Lauren Hartzenberg
  • Business unusual for small enterprises on the road to recovery
    The Covid-19 pandemic has hit South Africa's small business sector hard and there are grim statistics to bear this out. Those statistics will not be repeated here. After all, if you are a small business owner setting out on the road to recovery, the last thing you probably want is more details of the toll the pandemic has taken on small enterprises. Far more useful would be some good, solid tips on how to build back better after any business setbacks. By Ameen Hassen
Show more
Advertise on Bizcommunity

Subscribe to industry newsletters

South African health inspectors will not release unsuitable J&J vaccines

South African health inspectors on Sunday said they will not release Johnson & Johnson Covid-19 vaccines that may have been contaminated during production at a US plant.
Vials labelled "Covid-19 coronavirus vaccine" and syringe are seen in front of displayed Johnson & Johnson logo in this illustration taken, February 9, 2021. Reuters/Dado Ruvic/File Photo
The South African Health Products Regulatory Authority (Sahpra) said it made the decision after the US Food and Drug Administration (FDA) raised concerns over manufacturing practices at the Baltimore plant.

"Sahpra reviewed the data provided by the FDA and has made a decision not to release vaccine produced using the drug substance batches that were not suitable,” Sahpra said in a statement.

The findings by the FDA would impact two million vaccines that are awaiting release at Aspen Pharmacare's Gqeberha manufacturing site, acting health minister Mmamoloko Kubayi-Ngubane said on national broadcaster, SABC.

Kubayi-Ngubane said the government was in talks with J&J over replacing the affected vaccines.

Fears of a third Covid-19 wave are mounting in the country, which has recorded the highest number of infections and deaths on the continent, with daily infections rising to over 9,000 per day.

South Africa launched phase two of its vaccine rollout in May, aiming to inoculate fiv- million people aged over 60 by the end of June.

Local heath regulators said 300,000 doses of the J&J vaccine have been cleared by the FDA and will be shipped to South Africa.

Manufacturing at the Baltimore plant was halted in April after it was discovered that ingredients from AstraZeneca's Covid-19 vaccine, produced at the plant at the time, had contaminated a batch of J&J's vaccine.

A further inspection by the FDA also turned up a long list of sanitary problems and bad manufacturing practices at the Emergent plant.


Reuters, the news and media division of Thomson Reuters, is the world's largest multimedia news provider, reaching billions of people worldwide every day.
Go to:

Let's do Biz